title: Association of rheumatoid arthritis risk with EGFR genetic polymorphisms in Taiwan's Han Chinese population.
abstract: The involvement of the epidermal growth factor receptor (EGFR) in the pathogenesis of cancer is well documented. In contrast, its role in rheumatoid arthritis (RA) development is not that well defined although previous studies suggested the possible link between autoimmune diseases and malignancy. Therefore, we aimed to examine whether there is a link between the EGFR genetic polymorphisms and the RA. Our study gauged the effects of EGFR (rs11543848 and rs17337023) single-nucleotide polymorphisms (SNPs) on RA among Taiwan's Han Chinese population. Polymorphism of EGFR gene was analyzed in 188 RA patients and 128 control subjects. Genotyping for EGFR SNPs was performed by restriction fragment length polymorphism (RFLP) assay. Our data confirmed statistically significant increased risk of RA development in subjects with A carrier at rs17337023 SNP (P < 0.0001), and subjects with A allele at rs17337023 SNP (odds ratio [OR] = 1.52; 95% confidence interval [CI] = 1.10-2.09). Furthermore, comparison of haplotype frequencies between patients and controls suggested GA and AT haplotypes were more "at-risk" for RA development (P < 0.0001 and P < 0.01, respectively). However, comparisons of the clinical features of RA patients according to different genotypes and haplotypes revealed no significant difference. In conclusion, our data yield the new information on EGFR polymorphisms (rs11543848 and rs17337023) with the susceptibility of RA development and polymorphism revealed by this study merit further investigation.
authors: Department of Physical Medicine and Rehabilitation, China Medical University Hospital, Taichung, Taiwan.
authors: Sui-Foon
authors: SF
authors: Lo
authors: Lei
authors: L
authors: Wan
authors: Hsiu-Chen
authors: HC
authors: Lin
authors: Chung-Ming
authors: CM
authors: Huang
authors: Shih-Yin
authors: SY
authors: Chen
authors: Su-Ching
authors: SC
authors: Liu
authors: Fuu-Jen
authors: FJ
authors: Tsai
references: FASEB J. 2003 Feb;17(2):136-43
references: 12554692
references: J Inflamm (Lond). 2008 Apr 27;5:5
references: 18439312
references: Clin Cancer Res. 2007 Jun 15;13(12):3597-604
references: 17575224
references: Cancer Res. 1999 Aug 15;59(16):4142-7
references: 10463620
references: Nature. 1984 May 31-Jun 6;309(5967):418-25
references: 6328312
references: Lupus. 2004;13(10):773-6
references: 15540509
references: Cytokine. 1990 Jul;2(4):294-9
references: 2104229
references: Int Rev Immunol. 1998;17(5-6):365-81
references: 10036640
references: Fertil Steril. 2005 Mar;83(3):796-9
references: 15749523
references: Arthritis Res Ther. 2008;10(2):R45
references: 18433475
references: Arthritis Rheum. 2005 May;52(5):1481-90
references: 15880596
references: Biochim Biophys Acta. 2008 Apr;1785(2):232-65
references: 18291115
references: Int J Biochem Cell Biol. 1999 Jun;31(6):637-43
references: 10404636
references: J Cancer Res Clin Oncol. 2009 Feb;135(2):313-8
references: 18726117
references: Clin Immunol Immunopathol. 1996 Oct;81(1):27-34
references: 8808638
references: Curr Opin Cell Biol. 1999 Apr;11(2):190-6
references: 10209155
references: Cell Mol Life Sci. 2008 May;65(10):1566-84
references: 18259690
references: Curr Opin Cell Biol. 1999 Apr;11(2):184-9
references: 10209149
references: Scand J Rheumatol. 2005 May-Jun;34(3):204-11
references: 16134726
references: J Rheumatol. 1995 Aug;22(8):1450-4
references: 7473464
references: BMC Med Genet. 2008 Jul 30;9:74
references: 18664296
references: Curr Opin Rheumatol. 2003 May;15(3):274-9
references: 12707581
references: Biochem Biophys Res Commun. 1995 May 25;210(3):1066-75
references: 7763235
references: Oncogene Res. 1987 Sep-Oct;1(4):375-96
references: 3329716
references: Arthritis Rheum. 1988 Mar;31(3):315-24
references: 3358796
references: Semin Arthritis Rheum. 1992 Apr;21(5):317-29
references: 1351318
references: Eur J Cancer. 2001 Sep;37 Suppl 4:S3-8
references: 11597398